|
COPYRIGHT 2001 Centaur Publishing Ltd.
Cantab Pharmaceuticals, a UK vaccine developer, said it will sell itself to Slough-based biotechnology company Xenova Group. The deal comes four months after Cantab put itself up for sale following the 67% one-day drop in its shareprice last October.
Nick Hart, acting CEO of Cantab said: "The enlarged group brings together two companies with a joint focus on cancer and...
Read the full article for free courtesy of your local library.
|